AUCTORES
Globalize your Research
Research Article | DOI: https://doi.org/10.31579/2641-0419/157
*Corresponding Author: Hammam Shereef, MD. Department of Internal Medicine. Beaumont Health – Dearborn 18101 Oakwood Blvd, Dearborn, Michigan, 48124
Citation: Hammam Shereef., Ahmed S Yassin., Mowyad Khalid., Omeralfaroug Adam., Hossam Abubakar., (2021) The Medico-economic Impacts of Marijuana Use on the Outcomes and In-hospital Mortality in Patients with Atrial Fibrillation – Nationwide Database study. J. Clinical Cardiology and Cardiovascular Interventions, 4(11); DOI:10.31579/2641-0419/157
Copyright: © 2021 Hammam Shereef, This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 26 March 2021 | Accepted: 20 May 2021 | Published: 27 May 2021
Keywords: atrial fibrillation; marijuana smoking; outcomes; mortality; length of stay; cost of hospitalization; nis database
Introduction
Cannabinoid users are at high risk of developing atrial arrhythmias. We sought to investigate the outcomes and the economic impact of marijuana use on patients with atrial fibrillation utilizing the National Inpatient Sample.
Materials and Methods
Patients with atrial fibrillation were identified in the National Inpatient Sample (NIS) database between 2012 and 2014 using the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM), who subsequently were divided into two groups, those with and without marijuana smoking. The primary outcome was all-cause in-hospital mortality in the two groups. Secondary outcomes were in-hospital morbidities, required procedures and complications. We also evaluated the length of hospital stay and the cost of hospitalization. Logistic regression model was performed to address potential confounding factors.
Results:
The marijuana-users group had no significant increase of in-hospital mortality (OR: 1.24; 95% CI: 0.51 - 3.01, p = 0.632). However, marijuana users were predominantly younger males and less likely to undergo cardiac surgery (OR: 0.54, 95% CI 0.37 - 0.78, p = 0.001). Moreover, marijuana users are more likely to have a lower cost of hospitalization when compared to non-users ($28,916 vs $32,303, p = 0.001).
Conclusion:
Cannabinoid use was not associated with an increase in mortality among patients admitted with atrial fibrillation. However, marijuana users were younger, had fewer comorbidities, and cardiac surgeries with associated lower hospitalization costs. Admittedly, given the growing popularity of these products, further large prospective studies are needed to investigate the safety and evaluate different integral associations of cannabis use with worse cardiac outcomes in atrial arrhythmias patients, particularly those with atrial fibrillation.
Atrial fibrillation is the most common documented cardiac arrythemia that is known to be associated with adverse outcomes across multiple large studies, with almost twice the risk of cardiovascular events including mortality[1-3]. Very little is known about the impact of marijuana smoking in patients with atrial fibrillation. Currently, Cannabinoids are being used as therapeutic agents for many medical conditions [4], it’s illegal use for decades is well recorded but less studied. Nowadays, we are moving toward legalization of these agents and the number of users is increasing by the day, especially among young and middle-age populations. The safety of marijuana needs to be established and challenged prior to its full legalization. Many studies were conducted to evaluate marijuana effect on cardiovascular system [5-7]. De Filippis et al. conducted a retrospective study in adults over 50 years old who presented with acute coronary syndromes (ACS), around 10% of the patients with STEMI had recently used cocaine or marijuana, and these patients were associated with worse all-cause mortality compared to patients without use [5]. Rezkalla et al. report in 2018 discussed the temporal relationship between marijuana use and a variety of cardiovascular events, where they reported effects like atrial fibrillation, ventricular tachycardia, acute coronary syndromes, congestive heart failure, accelerated hypertension, cerebrovascular disease, and even sudden death [7,8]. Yet the current evidence appears to be insufficient to conclude the effects of marijuana smoking on cardiovascular events. In our study, we aimed to evaluate the impact of marijuana smoking on the outcome of patients with atrial fibrillation.
Data source:
We conducted our study utilizing the National Inpatient Sample (NIS) database in the period between 2012-2014. The NIS is considered the largest all-payer database of in-hospital stays in the United States, developed by the Agency for Healthcare Research and Quality (AHRQ) as part of its Healthcare Cost and Utilization Project (HCUP) initiative [9]. The NIS includes more than seven million unweighted hospitalizations per year. Discharge weights provided within the database can be applied. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) coding used to provide 25 to 30 discharge diagnoses, depending on the year and 15 procedures on each hospitalization. NIS discharge records include diagnoses, basic demographics, procedures, insurance payers, length of stay, hospital characteristics, and hospital charges. As the data collected from NIS, no IRB approval was required to be obtained.
Variables and outcomes:
NIS registry discharge from 2012 to 2014 studied in a retrospective cohort fashion. We used validated ICD-9 codes to include adults (≥18 years) hospitalized with a principal diagnosis of Atrial fibrillation. (Table 1) depicts the ICD-9 codes used. Patients’ demographics and baseline clinical characteristics are shown in (Table 2). Charlson comorbidity index calculated for comorbidities. Atrial Fibrillation patients with Marijuana use were compared to patients without Marijuana in characteristics, length of stay, acute kidney injury (AKI), venous thrombo-embolism (DVT/PE), ICU admission, cardiogenic shock, ventricular arrhythmias, cardiac arrest, need for permanent pacemaker, open-heart surgeries, and other vascular and cardiac complications. The primary outcome is in-hospital mortality.
Statistical analysis:
We used STATA 15 (Stata Corp, College Station, Texas, USA) to perform statistical analyses in our study sample. Categorical variables are expressed in percentages and continuous outcomes reported in mean +/- standard deviation (SD). We utilized Discharge weights and excluded patients with missing data. Chi-square test and student’s t-test used for categorical and continuous variables, respectively. To compare groups, we used logistic regression model for categorical outcomes, and linear regression for continuous outcomes. Statistical significance was determined based on the p-value of < 0.05. For outcomes, numeric results reported as mean and binary outcomes reported as an odds ratio.
We studied 1,260,015 patients from the NIS registry between 2012 and 2014; patients were all hospitalized with principal diagnosis of atrial fibrillation divided into two cohorts with and without use of marijuana. We found a mean age of 70 ± 13 years in the non-marijuana users arm compared to significantly younger patients’ population in the marijuana use arm with mean age of 49 ± 13 years. Female to male ratio was calculated as 1:1 in the overall study subjects, yet more male predominance was found in the atrial fibrillation marijuana arm accounting for 84.94%. Our study claimed majority of white populations followed by African Americans followed by Hispanics with 82.96%, 7.68%, and 5.4% respectively, however we noted a higher percentage of African Americans and Hispanics in atrial fibrillation marijuana cohort as compared non-marijuana cohort; 29.34%, and 7.9% respectively. In analysis of patient’s geographical distribution, it was noted that majority of them were admitted to south region hospitals followed by Midwest then Northeast followed by west region; 39.58%, 24.61%, 20.92% and 14.89% respectively. We also depicted that more than two thirds of sample covered by Medicare, followed by private insurances followed by Medicaid: 69.3%, 22.73% and 4.86% respectively. Charlson’s index reported more than two-thirds of study subjects to have more than one co-morbidity and in further subgroup analyses we were able to show more frequencies of tobacco smoking, alcohol abuse and hyperthyroidism in marijuana users with atrial fibrillation versus non-marijuana group (54.18% tobacco smoking, 22.31% for alcohol abuse and 3.19% for hyperthyroidism compared to 10.12%, 2.52% and 1.64% respectively), however less frequencies of coronary artery disease (CAD) and chronic kidney disease (CKD) observed in the marijuana users compared to non-users (17.21% for CAD and 5.34% for CKD in comparison to 30.29% and 9.13% in the non-users group) all baseline demographics and clinical characteristics shown in (Table 1). After adjusting for patient-level characteristics, the crude and adjusted odds ratio by logistic regression model between the two groups in (Table 2), showed no significant statistical difference in in- hospital mortality between the two groups (OR 1.24; 95% CI: 0.51-3.01, P = 0.844). However, in regards to secondary in-hospital outcomes analysis we elicited fewer incidences of open-heart surgeries in marijuana cohort (OR 0.47; 95% CI: 0.37-0.78, P = 0.001). The length of hospital stay was not found to be statistically significant, however our data showed less hospital expenditure documented in marijuana admissions after adjustment for inflation; 28,916 USD as opposed to 32,303 USD in non-marijuana (Table 3).
Although some studies provided evidence that cannabinoids have noticeable hemodynamic and possible arrhythmogenic effect, the impact of marijuana smoking on clinically significant arrhythmias remains unclear. The most reported finding is tachycardia that lasts few hours after smoking, due to possible enhanced sinoatrial tissue automaticity and reduced parasympathetic tone [10-12]. In one study utilizing the National Inpatient Sample (NIS) database, it was found that cannabis use has been linked to increase inpatient admissions with arrhythmias [13].
Our study aimed to evaluate the impact of marijuana use in atrial fibrillation population using a (NIS) database. The usage of such databases allow for inclusivity of larger number of patients and utilization of logistic regression model will allow correcting for confounders. Also, the clinical relevance of such study is important considering the increased thromboembolic risk associated even with short periods AF, especially in patients with other risk factors for thromboembolism [14]. Recent report by Desai et. al. has used NIS to study marijuana-smoking relation to atrial arrhythmia as a whole than a specific type in particular [15]. Korntzopoulos et al, speculated a possible mechanisms of marijuana smoking causing AF, summarizing multifactorial scheme of neurohormonal factors and flow effects as sympathetic system activation, ischemia, impaired coronary microcirculation, increased pulmonary vein ectopy, enhanced atrial electrical remodeling, and increased dispersion of refractoriness [16]. From this we concluded that marijuana smoking impact of patients with atrial fibrillation warrants further studying and evaluation.
Our study showed that there is no increase in in-hospital mortality among marijuana smokers when they present with atrial fibrillation. However, most of the marijuana users were younger and with less co-morbidities. Another issue that the marijuana smoking status might be more prevalent in the labeled nonsmokers’ group than reported, this is since not all smokers would admit usage and marijuana urine testing is not routinely conducted in clinical settings outside the scope of employment screening.
It’s not completely clear why the marijuana smoking group requires less open-heart surgeries, possibly their young age, and their scarce co-morbidities especially the lower rates of coronary artery disease (CAD) incidence noted in the baseline characteristics. Same group was also found to require lower cost of hospitalization that can be explained by their less complexed admission compared to more older individuals who require more aggressive therapies including procedures, surgeries, and intensive care stay.
There are several recognized limitations of our study to be considered. First, the NIS database does not capture variables related to atrial fibrillation (e.g., CHADVAS score, chronicity, underlying structural heart disease, atrial diameter, previous trails of cardioversion or ablation) and marijuana smoking (e.g., chronicity, poly-substance use) or the treatment provided to the patients. Second, the use of a registry database to calculate the prevalence and the impact of marijuana smoking is well known to be at risk of coding errors. Various studies have shown that disparities in coding practice and documentation can significantly affect the observed prevalence and outcome of any condition in the NIS database. Finally, the outcome data are limited to in-hospital events and long-term impact and outcomes could not be assessed. Despite these recognized limitations, the NIS database is a valuable tool and has been widely used and validated.
Cannabinoid use was not associated with an increase in mortality among patients admitted with atrial fibrillation. However, marijuana users were younger, had fewer comorbidities, and cardiac surgeries with associated lower hospitalization costs. Admittedly, given the growing popularity of these products, further large prospective studies are needed to investigate the safety and evaluate different integral associations of cannabis use with worse cardiac outcomes in atrial arrhythmias patients, particularly those with atrial fibrillation.
Conflict of interest: None of the authors have any conflicts of interest to declare.
Disclosure of funding: None of the authors have any source of funding to declare.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
